Neuroendocrine influences on cancer progression
暂无分享,去创建一个
Steve W. Cole | A. Sood | S. Cole | S. Lutgendorf | G. Armaiz-Pena | Anil K. Sood | Guillermo N. Armaiz-Pena | Susan K. Lutgendorf
[1] R. Pollock,et al. Mechanism of surgical stress impairment of human perioperative natural killer cell cytotoxicity. , 1991, Archives of surgery.
[2] M. Caron,et al. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] J. Otten,et al. Personality factors and breast cancer risk: a 13-year follow-up. , 2008, Journal of the National Cancer Institute.
[4] Timothy R. Crespin,et al. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments , 2007, Brain, Behavior, and Immunity.
[5] George Kulik,et al. Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-dependent Protein Kinase and BAD Phosphorylation* , 2007, Journal of Biological Chemistry.
[6] B. Flaxman,et al. In vitro analysis of the control of keratinocyte proliferation in human epidermis by physiologic and pharmacologic agents. , 1975, The Journal of investigative dermatology.
[7] A. Sood,et al. Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth , 2011, Clinical Cancer Research.
[8] C. Shapiro,et al. Biobehavioral, Immune, and Health Benefits following Recurrence for Psychological Intervention Participants , 2010, Clinical Cancer Research.
[9] J. Bos,et al. Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor , 2003, The Journal of cell biology.
[10] R. MacCallum,et al. Stress and immune responses after surgical treatment for regional breast cancer. , 1998, Journal of the National Cancer Institute.
[11] J. Kaprio,et al. Stressful life events and risk of breast cancer in 10,808 women: a cohort study. , 2003, American journal of epidemiology.
[12] R. MacCallum,et al. Hormonal modulation of Epstein-Barr virus replication. , 1995, Neuroendocrinology.
[13] A. Sood,et al. Psychosocial factors and interleukin‐6 among women with advanced ovarian cancer , 2005, Cancer.
[14] B. McEwen. Protective and damaging effects of stress mediators. , 1998, The New England journal of medicine.
[15] I. Bairati,et al. Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada) , 2004, Cancer Causes & Control.
[16] B. Marchetti,et al. A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: Hormonal control of β-adrenergic receptors and correlation with tumor growth , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[17] A. Flahault,et al. [Could treatments with beta-blockers be associated with a reduction in cancer risk?]. , 2004, Revue d'epidemiologie et de sante publique.
[18] Liz Y. Han,et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. , 2008, Journal of the National Cancer Institute.
[19] Kunhong Xiao,et al. A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1 , 2011, Nature.
[20] Steve W. Cole,et al. Neuroendocrine modulation of cancer progression , 2009, Brain, Behavior, and Immunity.
[21] K. Bennett,et al. Beta blockers and breast cancer mortality: a population- based study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. During,et al. Environmental and Genetic Activation of a Brain-Adipocyte BDNF/Leptin Axis Causes Cancer Remission and Inhibition , 2010, Cell.
[23] F. Entschladen,et al. Tumor interactions with soluble factors and the nervous system , 2010, Cell Communication and Signaling.
[24] Steven W. Cole,et al. Molecular Pathways: Beta-Adrenergic Signaling in Cancer , 2011, Clinical Cancer Research.
[25] F. Penedo,et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. Sun,et al. β-Adrenoreceptors Reactivate Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication via PKA-Dependent Control of Viral RTA , 2005, Journal of Virology.
[27] I. Rabinovitz,et al. Towards a mechanistic understanding of tumor invasion--lessons from the alpha6beta 4 integrin. , 2001, Seminars in cancer biology.
[28] S. Basu,et al. Depleted Dopamine in Gastric Cancer Tissues , 2004, Clinical Cancer Research.
[29] P. McDonald,et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms , 2006, Nature Reviews Cancer.
[30] David A. Tuveson,et al. Maximizing mouse cancer models , 2007, Nature Reviews Cancer.
[31] F. Dhabhar,et al. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer , 2009, Brain, Behavior, and Immunity.
[32] G. Bronnikov,et al. Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a β-Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2* , 2000, The Journal of Biological Chemistry.
[33] A. Sood,et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] A. Sood,et al. Vascular endothelial growth factor and social support in patients with ovarian carcinoma , 2002, Cancer.
[35] C. Carver,et al. Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study. , 2009, Journal of psychosomatic research.
[36] J. Bahr,et al. Norepinephrine in the rat ovary: ontogeny and de novo synthesis. , 1984, Endocrinology.
[37] J. Cacioppo,et al. Autonomic and Glucocorticoid Associations with the Steady-State Expression of Latent Epstein–Barr Virus , 2002, Hormones and Behavior.
[38] S. Lemeshow,et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. , 2006, Cancer research.
[39] A. Castrucci,et al. Catecholamine effects on human melanoma cells evoked by α1-adrenoceptors , 2004, Archives of Dermatological Research.
[40] F. Penedo,et al. Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma , 2008, Clinical Cancer Research.
[41] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[42] S. Lakhani,et al. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. , 1999, Cancer research.
[43] David B Jackson,et al. Src activation by β-adrenoreceptors is a key switch for tumor metastasis , 2012, Nature Communications.
[44] S. Ojeda,et al. Prepubertal ovarian function is finely regulated by direct adrenergic influences. Role of noradrenergic innervation. , 1984, Endocrinology.
[45] D. Golden-Kreutz,et al. Psychologic intervention improves survival for breast cancer patients , 2008, Cancer.
[46] Liz Y. Han,et al. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. , 2007, Cancer research.
[47] Liz Y. Han,et al. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. , 2010, The Journal of clinical investigation.
[48] Stanley Lemeshow,et al. Chronic stress and susceptibility to skin cancer. , 2005, Journal of the National Cancer Institute.
[49] D. Mukhopadhyay,et al. Ablation of Peripheral Dopaminergic Nerves Stimulates Malignant Tumor Growth by Inducing Vascular Permeability Factor/Vascular Endothelial Growth Factor-Mediated Angiogenesis , 2004, Cancer Research.
[50] M. von Knebel Doeberitz,et al. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. , 2003, Cancer research.
[51] Liz Y. Han,et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma , 2006, Nature Medicine.
[52] G. Maestroni. Neurohormones and Catecholamines as Functional Components of the Bone Marrow Microenvironment , 2000, Annals of the New York Academy of Sciences.
[53] Janice A. Nagy,et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor , 2001, Nature Medicine.
[54] J. Bos,et al. Epac proteins: multi-purpose cAMP targets. , 2006, Trends in biochemical sciences.
[55] J. Kiecolt-Glaser,et al. Stress-induced immune dysfunction: implications for health , 2005, Nature Reviews Immunology.
[56] S. Ojeda,et al. An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. , 2000, Endocrinology.
[57] Liz Y. Han,et al. Stress Hormone–Mediated Invasion of Ovarian Cancer Cells , 2006, Clinical Cancer Research.
[58] A. Sood,et al. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients , 2008, Brain, Behavior, and Immunity.
[59] T. Seeman,et al. Computational identification of gene-social environment interaction at the human IL6 locus , 2010, Brain, Behavior, and Immunity.
[60] A. Sood,et al. Social support, psychological distress, and natural killer cell activity in ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] P. Butow,et al. The role of psychosocial factors in the development of breast carcinoma: Part II , 2001, Cancer.
[62] G. Kunos,et al. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells. , 1990, Journal of Immunology.
[63] A. Sood,et al. Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism* , 2007, Journal of Biological Chemistry.
[64] A. Sood,et al. Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis* , 2010, The Journal of Biological Chemistry.
[65] G. Shakhar,et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity , 1999, International journal of cancer.
[66] Anil K Sood,et al. Impact of stress on cancer metastasis. , 2010, Future oncology.
[67] G. Hortobagyi,et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] M. Zeegers,et al. The association between stressful life events and breast cancer risk: A meta‐analysis , 2003, International journal of cancer.
[69] P. Butow,et al. The role of psychosocial factors in the development of breast carcinoma: Part I , 2001, Cancer.
[70] D. Powe,et al. Targeted therapies: Using β-blockers to inhibit breast cancer progression , 2011, Nature Reviews Clinical Oncology.
[71] E. Sternberg,et al. Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.